reflects the huge growth in importance of organometallic chemistry and the very different problems associated with the presence of p-bonded ligands. Chapter IR-9 is also considerably changed (cf. Red Book I, Chapter I-10). This revised chapter includes a clarification of the use of the Z and k conventions in coordination and organometallic compounds (Section IR-9.2.4.3); new rules for the ordering of central atoms in names of polynuclear compounds (Section IR-9.2.5.6); the bringing together of sections on configuration (Section IR-9.3) and their separation from those on constitution (Section IR-9.2); and the addition of polyhedral symbols for T-shaped (Section IR-9.3.3.7) and see-saw (Section IR-9.3.3.8) molecules, along with guidance on how to choose between these shapes and those of closely related structures (Section IR-9.3.2.2).
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The reader facing the problem of how to name a given compound or species may find help in several ways. A flowchart is provided in Section IR-1.5.3.5, which will in most cases guide the user to a section or chapter where rules can be found for generating at least one possible name; a second flowchart is given in Section IR-9.2.1 to assist in the application of additive nomenclature, specifically to coordination and organometallic compounds. A more detailed subject index is also provided, as is an extended guide to possible alternative names of a wide range of simple inorganic compounds, ions and radicals. Statistically, every second drug is an analogue, and their market value amounts to two-thirds of all drugs. Analogues are the most successful way of inventing a new drug and they provide the required improvements in drug therapy. This is the first authoritative overview of past and current strategies for successful drug development by molecular modification of known leads. The book is a unique resource, which spans the important drug classes in most major therapeutic fields.
Analogue-based drug discovery is discussed among others, for beta blockers, ACE inhibitors, steroids, opiates, stigmines, proton pump inhibitors, platinum anticancer compounds, and antiinfective quinolones. Case studies, by the respective inventors of selected commercially successful drug analogues provide prime advice for new drug development projects based on analogue modification. The book includes a table of the most successful drug analogues as based on the IMS ranking and compares them in terms of chemical structure, mode of action, launch year, and patent priority. 
